BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34393224)

  • 21. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
    Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
    Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Campbell SC; Gill IS
    J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic upstaging after laparoscopic radical nephrectomy.
    Goel MC; Mohammadi Y; Sethi AS; Brown JA; Sundaram CP
    J Endourol; 2008 Oct; 22(10):2257-61. PubMed ID: 18937590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery].
    Tang Q; Lin RC; Yao L; Zhang Z; Hao H; Zhang CJ; Cai L; Li XS; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):628-631. PubMed ID: 31420612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
    Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
    J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.
    Delto JC; Paulucci D; Helbig MW; Badani KK; Eun D; Porter J; Abaza R; Hemal AK; Bhandari A
    BJU Int; 2018 Jun; 121(6):908-915. PubMed ID: 29357404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
    Pruthi DK; Miller G; Ankerst DP; Neumair M; Capitanio U; Correa AF; Lane BR; Roussel E; McGregor TB; Derweesh IH; Cordeiro M; Pierorazio PM; Calvo C; Bi H; Noyes SL; Meagher M; Kutikov A; Uzzo RG; Van Poppel H; Larcher A; Montorsi F; Kattan MW; Kaushik D; Liss MA
    J Urol; 2023 Nov; 210(5):750-762. PubMed ID: 37579345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
    Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
    Xing Z; Xu H; Ai K; Deng H; Hong Y; Deng P; Wang J; Xiong W; Li Z; Zhu L; Li Y
    Ann Surg Oncol; 2024 May; 31(5):3531-3543. PubMed ID: 38329657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison and development of preoperative systemic inflammation markers-based models for the prediction of unfavorable pathology in newly diagnosed clinical T1 renal cell carcinoma.
    Liu H; Tang K; Chen Z; Li Z; Meng X; Xia D
    Pathol Res Pract; 2021 Sep; 225():153563. PubMed ID: 34371466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes after partial vs radical nephrectomy in renal cell carcinomas of ≤7 cm with presumed renal sinus fat invasion on preoperative imaging.
    Koo KC; Kim JC; Cho KS; Choi YD; Hong SJ; Yang SC; Ham WS
    BJU Int; 2016 Jan; 117(1):87-93. PubMed ID: 25099267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Assessment of Renal Sinus Invasion by Renal Cell Carcinoma according to Tumor Complexity and Imaging Features in Patients Undergoing Radical Nephrectomy.
    Kim JH; Park KJ; Kim MH; Kim JK
    Korean J Radiol; 2021 Aug; 22(8):1323-1331. PubMed ID: 34047502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
    Mouracade P; Dagenais J; Chavali JS; Kara O; Nelson RJ; Maurice MJ; Reese J; Rini BI; Kaouk JH
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1077-e1082. PubMed ID: 28818550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study.
    Antonelli A; Ficarra V; Bertini R; Carini M; Carmignani G; Corti S; Longo N; Martorana G; Minervini A; Mirone V; Novara G; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Cunico SC;
    BJU Int; 2012 Apr; 109(7):1013-8. PubMed ID: 21883829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis.
    Chow AK; Kahan AN; Hwang T; Coogan CL; Latchamsetty KC
    Urology; 2018 Dec; 122():127-132. PubMed ID: 30205104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.